Search research articles
Contact Us
Filters
Showing results (371-380 of 377) with videos related to
Page
of 38
Sort By:
You have reached the last page of results.
This site can display upto 377 results.
British Journal of Cancer
|
February 24, 2023
The HLA ligandome of oropharyngeal squamous cell carcinomas reveals shared tumour-exclusive peptides for semi-personalised vaccination
Lena Mühlenbruch, Tsima Abou-Kors, Marissa L Dubbelaar, et al.
Frontiers in Immunology
|
August 13, 2024
Multi-omics analysis of overexpressed tumor-associated proteins: gene expression, immunopeptide presentation, and antibody response in oropharyngeal squamous cell carcinoma, with a focus on cancer-testis antigens
Tsima Abou Kors, Matthias Meier, Lena Mühlenbruch, et al.
Critical Care (London, England)
|
July 11, 2025
Effects of dapagliflozin on urinary output, fluid balance, and biochemistry in critically ill patients: a post-hoc secondary analysis of the DEFENDER trial
Fernando G Zampieri, Luciano C P Azevedo, Ary Serpa Neto, et al.
International Journal of Cancer
|
August 14, 2019
Patterns of antibody responses to nonviral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status
Dominik S Gangkofner, Dana Holzinger, Lea Schroeder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 25, 2019
Antibody Responses to Cancer Antigens Identify Patients with a Poor Prognosis among HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Patients
Simon Laban, Dominik S Gangkofner, Dana Holzinger, et al.
HNO
|
January 27, 2021
[Effects of the SARS-CoV‑2 pandemic on the otolaryngology university hospitals in the field of research, student teaching and specialist training]
T Stöver, S Dazert, S K Plontke, et al.
JAMA
|
June 14, 2024
Dapagliflozin for Critically Ill Patients With Acute Organ Dysfunction: The DEFENDER Randomized Clinical Trial
Caio A M Tavares, Luciano C P Azevedo, Álvaro Rea-Neto, et al.
Page
of 38
Search research articles
Search
Showing results (371-380 of 377) with videos related to
Sort By:
Page
of 38
You have reached the last page of results.
This site can display upto 377 results.
British Journal of Cancer
|
February 24, 2023
The HLA ligandome of oropharyngeal squamous cell carcinomas reveals shared tumour-exclusive peptides for semi-personalised vaccination
Lena Mühlenbruch, Tsima Abou-Kors, Marissa L Dubbelaar, et al.
Frontiers in Immunology
|
August 13, 2024
Multi-omics analysis of overexpressed tumor-associated proteins: gene expression, immunopeptide presentation, and antibody response in oropharyngeal squamous cell carcinoma, with a focus on cancer-testis antigens
Tsima Abou Kors, Matthias Meier, Lena Mühlenbruch, et al.
Critical Care (London, England)
|
July 11, 2025
Effects of dapagliflozin on urinary output, fluid balance, and biochemistry in critically ill patients: a post-hoc secondary analysis of the DEFENDER trial
Fernando G Zampieri, Luciano C P Azevedo, Ary Serpa Neto, et al.
International Journal of Cancer
|
August 14, 2019
Patterns of antibody responses to nonviral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status
Dominik S Gangkofner, Dana Holzinger, Lea Schroeder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 25, 2019
Antibody Responses to Cancer Antigens Identify Patients with a Poor Prognosis among HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Patients
Simon Laban, Dominik S Gangkofner, Dana Holzinger, et al.
HNO
|
January 27, 2021
[Effects of the SARS-CoV‑2 pandemic on the otolaryngology university hospitals in the field of research, student teaching and specialist training]
T Stöver, S Dazert, S K Plontke, et al.
JAMA
|
June 14, 2024
Dapagliflozin for Critically Ill Patients With Acute Organ Dysfunction: The DEFENDER Randomized Clinical Trial
Caio A M Tavares, Luciano C P Azevedo, Álvaro Rea-Neto, et al.
Page
of 38